Robert Lechleider's most recent trade in Immunome Inc was a trade of 55,000 Common Stock done at an average price of $8.7 . Disclosure was reported to the exchange on July 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.73 per share. | 02 Jul 2026 | 55,000 | 70,805 | - | 8.7 | 480,150 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 55,000 | 290,000 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.95 per share. | 02 Jul 2026 | 22,714 | 48,091 | - | 21.9 | 498,572 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.76 per share. | 02 Jul 2026 | 16,214 | 31,877 | - | 22.8 | 369,031 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.44 per share. | 02 Jul 2026 | 16,072 | 15,805 | - | 23.4 | 376,728 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 55,000 | 345,000 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.73 per share. | 25 Jun 2026 | 55,000 | 70,805 | - | 8.7 | 480,150 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.56 per share. | 25 Jun 2026 | 40,580 | 30,225 | - | 19.6 | 793,745 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 25 Jun 2026 | 14,420 | 15,805 | - | 20.7 | 297,917 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 242,000 | 242,000 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 9.48 per share. | 21 Nov 2024 | 15,805 | 15,805 | - | 9.5 | 149,800 | Common Stock |
| Immunome Inc | Robert Lechleider | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) |